RecruitingPhase 3NCT07674654
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Sponsor: Kallyope Inc.
Birmingham, AL · Mobile, AL · +111 more sites
6 recruiting migraine studies with a site in Birmingham, AL.
Sponsor: Kallyope Inc.
Birmingham, AL · Mobile, AL · +111 more sites
Sponsor: Pfizer
Birmingham, AL · +168 more sites
Sponsor: Children's Hospital Medical Center, Cincinnati
Birmingham, AL · +14 more sites
Sponsor: Kallyope Inc.
Birmingham, AL · Mobile, AL · +111 more sites
Sponsor: AbbVie
Birmingham, AL · Huntsville, AL · +14 more sites
Sponsor: Upsher-Smith Laboratories
Birmingham, AL · +14 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.